Subash Jonnalagadda
Rowan University
H-index: 22
North America-United States
Top articles of Subash Jonnalagadda
Past, present, and a glance into the future of multiple myeloma treatment
2023/3/8
Autophagy and apoptosis: current challenges of treatment and drug resistance in multiple myeloma
2022/12/30
Hydrogel-encapsulated heterogenous mesoporous resin catalyst for in situ anti-cancer agent production under biological conditions
Biomolecules
2022/12/1
Baishali Kanjilal
H-Index: 9
Manoj Pandey
H-Index: 7
Subash Jonnalagadda
H-Index: 13
Robert Hesketh
H-Index: 8
Iman Noshadi
H-Index: 18
Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like …
Frontiers in Pharmacology
2022/9/9
Cancer on fire: role of inflammation in prevention and treatment
2022/1/1
Mcl-1 inhibition: managing malignancy in multiple myeloma
2021/7/19
Bruton’s tyrosine kinase targeting in multiple myeloma
2021/5/27
Old drugs, new uses: Drug repurposing in hematological malignancies
2021/1/1
Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents
Bioorganic & Medicinal Chemistry Letters
2016/4/15
Nucleic acid delivery with α-tocopherol-polyethyleneimine-polyethylene glycol nanocarrier system
International journal of nanomedicine
2020/9/11
Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents
Bioorganic & Medicinal Chemistry Letters
2020/7/15
Functionalized aminobenzoboroxoles
2020/4/28
Co-Authors
